Biotech

All Articles

Lykos will certainly inquire FDA to reevaluate its own selection following rejection of MDMA therapy for trauma

.Observing an unsatisfactory revealing for Lykos Therapeutics' MDMA candidate for trauma at a latest...

AN 2 fifty percents census, quits phase 3 test after information disappoint

.AN2 Rehabs is actually reassessing its own company in feedback to lackluster midphase records, pled...

Merck pays $700M for bispecific, snooping autoimmune opening and also opportunity to test Amgen in cancer cells

.Merck &amp Co. is actually spending $700 million in advance to challenge Amgen in a blood stream ca...

Gilead pays J&ampJ $320M to leave licensing package for seladelpar

.Along With Gilead Sciences almost an FDA decision for its liver health condition medicine seladelpa...

' All hands on deck' at Lilly as peers target obesity market

.Chief executive officer David Ricks can see the firms establishing camping tents at basecamp respon...

Entero giving up personnel, abandoning workplace and pausing R&ampD

.Cushion Liquidators has transformed Entero Therapeutics white colored as a piece. The creditor got ...

Exelixis loses ADC after choosing it's no match for Tivdak

.Exelixis is actually giving up on its own cells aspect (TF)- targeting antibody-drug conjugate afte...

Relay loses interest in SHP2 inhibitor after Genentech leaves

.3 weeks after Roche's Genentech system walked away from an SHP2 prevention pact, Relay Rehab has af...

Stoke's Dravet syndrome med launched of predisposed professional grip

.Stoke Therapeutics' Dravet syndrome medication has actually been actually without a partial grip, g...

Fierce Biotech's Gabrielle Masson presents Intense 15 at NYSE

.Intense Biotech Colleague Publisher Gabrielle Masson provided the 2024 class of Fierce 15 victors o...